GT
AHCO icon

Glenmede Trust’s AdaptHealth AHCO Stock Holding History

Glenmede Trust’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
29,065
+1,521
+6% +$17K ﹤0.01% 1180
2026
Q1 		$328K Buy
27,544
+291
+1% +$2.98K ﹤0.01% 1122
2025
Q4 		$271K Buy
+27,253
New +$260K ﹤0.01% 1180
2025
Q1 		$305K Buy
28,096
+4,086
+17% +$41.1K ﹤0.01% 1078
2024
Q4 		$229K Buy
24,010
+7,557
+46% +$76.5K ﹤0.01% 1196
2024
Q3 		$185K Buy
16,453
+4,556
+38% +$48.4K ﹤0.01% 1245
2024
Q2 		$119K Buy
+11,897
New +$121K ﹤0.01% 1240

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Glenmede Trust's AHCO Position: Q2 2026 in Review

Glenmede Trust increased its AdaptHealth (AHCO) stake by 5.5% in Q2 2026, buying an estimated $17K and bringing the position to 29,065 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Glenmede Trust first reported a position in AHCO in Q2 2024 and has held it in 7 quarters since. The position peaked at $328K in Q1 2026. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Glenmede Trust held 29,065 shares of AdaptHealth worth $303K as of Q2 2026.
  • Glenmede Trust bought 1,521 AdaptHealth shares in Q2 2026, an estimated $17K.
  • AdaptHealth made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1180 holding.
  • Glenmede Trust first reported a position in AdaptHealth in Q2 2024 and has held it in 7 quarters since.
  • Glenmede Trust's AdaptHealth position peaked at $328K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.